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Research
AbstrACt
Objectives Develop predictive models for a paediatric 
population that provide information for paediatricians 
and health authorities to identify children at risk of 
hospitalisation for conditions that may be impacted 
through improved patient care.
Design Retrospective healthcare utilisation analysis with 
multivariable logistic regression models.
Data Demographic information linked with utilisation 
of health services in the years 2006–2014 was used to 
predict risk of hospitalisation or death in 2015 using a 
longitudinal administrative database of 527 458 children 
aged 1–13 years residing in the Regione Emilia-Romagna 
(RER), Italy, in 2014.
Outcome measures Models designed to predict risk 
of hospitalisation or death in 2015 for problems that are 
potentially avoidable were developed and evaluated using 
the C-statistic, for calibration to assess performance 
across levels of predicted risk, and in terms of their 
sensitivity, specificity and positive predictive value.
results Of the 527 458 children residing in RER in 2014, 
6391 children (1.21%) were hospitalised for selected 
conditions or died in 2015. 49 486 children (9.4%) of the 
population were classified in the ‘At Higher Risk’ group 
using a threshold of predicted risk >2.5%. The observed 
risk of hospitalisation (5%) for the ‘At Higher Risk’ 
group was more than four times higher than the overall 
population. We observed a C-statistic of 0.78 indicating 
good model performance. The model was well calibrated 
across categories of predicted risk.
Conclusions It is feasible to develop a population-based 
model using a longitudinal administrative database 
that identifies the risk of hospitalisation for a paediatric 
population. The results of this model, along with profiles 
of children identified as high risk, are being provided to 
the paediatricians and other healthcare professionals 
providing care to this population to aid in planning for 
care management and interventions that may reduce 
their patients’ likelihood of a preventable, high-cost 
hospitalisation.
IntrODuCtIOn  
Healthcare systems have been moving from a 
passive approach of waiting for and reacting 
to patients’ problems to a more active model 
that includes identification of patients at 
risk, taking the initiative in offering care 
and actively seeking to avoid recurrence 
or progression of medical problems. With 
the ageing of populations worldwide, and 
high prevalence of chronic diseases, it is 
not surprising that these efforts have often 
focused on the elderly. Less attention has 
been paid to the paediatric population. 
However, despite the relatively low preva-
lence of chronic disease in children, there is 
evidence that children experience prevent-
able hospitalisations.1 For example, a study 
of paediatric inpatient claims in the USA esti-
mated that paediatric ‘ambulatory care sensi-
tive’ conditions accounted for US$4.05 billion 
in hospital charges and over 1 million hospi-
talisation days in a 1-year period.2 
Predictive risk modelling is a tool that can 
be used to estimate the risk of an outcome 
within the context of prespecified variables 
and uncertainty. Predictive risk modelling 
may offer an opportunity to better under-
stand individuals who may be at higher risk 
for an undesirable outcome.3 A number of 
predictive risk modelling studies have been 
conducted in paediatrics; however, many 
of these studies have focused on children 
strengths and limitations of this study
 ► This study included the entire paediatric population 
of the Emilia-Romagna Region of Italy, with a total of 
527 458 children ages 1–13 years.
 ► The study used an existing longitudinal administra-
tive healthcare database with both the advantage of 
much lower cost than new data collection and the 
disadvantage of gaps and potential errors in admin-
istrative data.
 ► The results of the study are being used to assist 
paediatricians and health authorities manage high-
risk children.
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with specific medical problems or use data that are not 
routinely available in administrative databases.4–9
Under the auspices of the Italian National Health Service 
(NHS), the 21 regional governments are responsible for 
delivering healthcare through a network of geographically 
defined Local Health Authorities. Primary care physicians, 
including paediatricians, work for the Local Health Author-
ities as independent contractors. Every Italian is expected 
to enrol with a primary care physician (a paediatrician for 
those under age 14 years) who serve as the ‘gatekeepers’ for 
delivering primary care and coordinating specialty services 
for their enrolled patients.10 This focus on primary care is 
ideal for the development and implementation of a proac-
tive model of healthcare.
To further encourage coordinated care, the Regione 
Emilia-Romagna (RER) has established Patient-Cen-
tered Medical Homes. The identification of patients who 
would most benefit from outreach efforts is fundamental 
to achieving the goals of promoting population health 
and practising proactive medicine. The RER has there-
fore developed and implemented a population-based 
model to predict risk of hospitalisation or death for 
adult residents in the region.11 The results of the model 
are presented to physicians in Patient-Centered Medical 
Homes as patient profiles to support care management 
and the identification of patients who may benefit from 
additional outreach such as home healthcare, disease 
management or case management.
Current risk models used in RER focus on the adult 
population. This paper describes the development of 
predictive risk models for the paediatric population using 
the RER’s regional longitudinal administrative healthcare 
database to help identify children who are at risk of hospi-
talisation for conditions that may be affected through 
improved patient care.
MethODs
Data source
The RER is a region of northern Italy that lies between 
the River Po and Apennine Mountains with approxi-
mately 4.5 million inhabitants. RER maintains a longitu-
dinal healthcare database for all its residents. The RER 
database contains patient-level demographic data (age, 
gender, birth and death dates, location of residence and 
primary care physician/paediatrician) and utilisation 
data for inpatient (hospital discharge abstract data with 
International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) diagnosis and proce-
dure codes and admission/discharge dates), outpatient 
(laboratory, diagnoses and physician services, and phar-
macy claims including WHO Anatomical Therapeutic 
Chemical (ATC)/Defined Daily Dose (DDD) system 
codes),12 specialty (therapeutic procedures, rehabili-
tation and specialist visits) and emergency room (ER) 
visits. Inpatient medications are not captured. Patients 
with disabilities or low family income are eligible for 
exemption of service copayment for specialty visits and 
outpatient prescriptions, which provide some socioeco-
nomic information. Each resident is assigned an anon-
ymous identifier so that utilisation can be tracked over 
time while maintaining patient privacy.13
study cohort
In Italy, children aged 14 years are required to switch 
from a paediatrician to a primary care physician; there-
fore, we limited the study population to children 1–13 
years old on 31 December 2014. The study population 
also was narrowed to exclude children who did not reside 
in RER for the entire year 2014. The study population 
was stratified into three age groups: 1–2 years old (on 31 
December 2014); 3–5 years old; and 6–13 years old. Chil-
dren less than 1 year old on 31 December 2014 were not 
included in the study population due to insufficient data 
for prediction of outcomes.
Dependent variable
The outcome was defined as the occurrence of hospi-
talisation that could have potentially been prevented or 
delayed with appropriate patient care or death by any 
cause.11 We developed a list of hospitalisations that are 
potentially preventable with appropriate patient care 
using a three-step process. First, we conducted a literature 
search to evaluate paediatric studies that defined poten-
tially avoidable disease in paediatrics that could require 
hospitalisation.14–16 We began with the listing of ICD-9-CM 
codes for ‘pediatric ambulatory care sensitive conditions’ 
identified in Shi and Lu.15 All hospitalisations in 2013 of 
children in the target age groups were classified using 
both ICD-9-CM codes and Disease Staging categories.17 18 
The results were reviewed by the authors of this paper and 
compared with Shi et al’s list. A number of changes were 
made for this project. For example, the list of immunisa-
tion preventable conditions to be included in the depen-
dent variable was expanded to include currently available 
vaccines. We included additional conditions, such as 
acute cystitis (ICD-9-CM code of 595.0) and hypogly-
caemic coma (ICD-9-CM code of 251.0). Advanced stages 
of selected medical problems were added where stage one 
may not be avoidable but advanced stages can potentially 
be delayed or prevented through timely intervention, for 
example, stage 2 or 3 appendicitis, stage 2 or 3 sinusitis. 
While certainly not always preventable, we believed that 
inclusion of hospitalisations for certain types of trauma 
and toxicities (eg, acetaminophen toxicity, adverse drug 
reactions and burns) was appropriate especially for a 
paediatric population. These changes are summarised in 
online supplementary appendix 1.
Finally, we used disease staging categories for inclusion 
of relevant hospitalisations that would have been missed 
using solely primary ICD-9-CM codes. For example, if a 
child was hospitalised with a primary diagnosis of respi-
ratory failure with asthma (ICD-9-CM code of 493) as 
the secondary diagnosis, then the disease staging cate-
gory of asthma would include that admission that might 
have been missed by including only primary ICD-9-CM 
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codes. This is summarised in online supplementary 
appendix 2.
Children hospitalised for these selected conditions or 
who died from any cause in 2015 were counted as being 
positive for the outcome.
Independent variables
A list of predictor variables was developed using the RER 
administrative data from 2006 to 2014. Independent 
variables included information such as: demographics, 
socioeconomic factors, diseases/conditions grouped by 
aetiology or body systems, mother’s medical history and 
pregnancy/birthing information, ER visits, potentially 
inappropriate prescriptions and antibiotic usage.
Demographic variables included age on 31 December 
2014, gender and citizenship (Italian or non-Italian). 
Children from low-income families or with disabilities are 
exempt from copayments for prescriptions and specialty 
visits. This information was used as a potential predictor 
variable.
We mapped diseases defined primarily by the affected 
body system with the exceptions of cancer, genetic condi-
tions and trauma, which were based on aetiology11 using 
2014 hospital discharge data, outpatient prescription 
information and specialty visit claims. A total of 24 groups 
were defined. Disease staging diagnostic categories was 
used to map hospital admissions to the 24 body system/
aetiology groups17 (see first column of table 1). Patients 
with cardiovascular diseases, chronic respiratory diseases, 
diabetes mellitus, epilepsy and disorders of the thyroid 
were identified using the ATC Classification System codes 
from outpatient prescriptions.19 Specialty visit records 
were also used for identifying medical conditions of 
some body systems. For example, if a child was admitted 
to the hospital for type 1 diabetes mellitus, or visited an 
endocrinologist, or had filled a prescription for insulin 
injection(s) (ATC code of A10AB), this patient would be 
identified as having an endocrine diagnosis in 2014.
Severity level codes (critical (C), acute (A), urgent but 
deferred (U) and not urgent (N)) are assigned to individ-
uals on discharge from the emergency department. We 
excluded ER visits that resulted in a hospital admission 
because diagnosis information was captured by hospital 
discharge data with more accurate information. We 
believe more frequent or severe ER visits may indicate a 
poor outcome; therefore, number of ER visits by severity 
level was calculated for each patient.
There is evidence that the risks outweigh the benefits 
for certain medication usage in the paediatric popula-
tion.20 For example, certain mood-altering medications 
such as, citalopram, sertraline, fluvoxamine and any tricy-
clic antidepressants are not recommended in children of 
any age. Some medications can be harmful within speci-
fied ages. For example, loperamide is not indicated for 
children under 3 years old. For children who filled an 
outpatient prescription in 2014, we calculated their age 
at dispensation date and amount of medications they 
had filled, in order to identify patients with potentially 
inappropriate prescriptions in 2014. The number of anti-
biotic prescriptions used in 2014 was estimated since high 
utilisation of antibiotics has been linked to decreased gut 
microflora, decreased immune function and resistant 
strains of bacteria.21
For children ages 1–5 years, the models considered 
problems identified at birth as potential predictors 
using hospital discharge abstract data. About 86% of the 
newborns were healthy, with no serious medical problems 
noted on their birth records. Infants with diagnostic cate-
gories of premature birth with low birth weight, full-term 
infants with abnormal birth weight, premature with very 
low birth weight or extremely low birth weight, were clas-
sified as abnormal birth weight; all other conditions were 
considered as a group. The mothers’ delivery informa-
tion, such as age at delivery, C-section and parity, were 
identified based on the mothers’ hospitalisation records 
and linked to children. Information about deliveries that 
occurred outside hospitals could not be captured.
Children ages 1–5 years old were also linked with infor-
mation regarding their mothers’ medical history and drug 
use during pregnancy. There is evidence on the associa-
tion between prenatal (up to 270 days before delivery) 
exposure to antibiotics and the development of asthma.22 
We estimated the total exposure to any antibiotics 
during the prenatal period using the mother outpatient 
prescription claims. We included two categories of moth-
er’s potentially inappropriate drug use, class D (poten-
tial risks outweigh the benefits) and X (contraindicated 
during pregnancy), since these drugs may be linked to 
harm to children. Mothers’ 3-year medical history before 
delivery was retrieved for identifying certain conditions 
such as abortion, diabetes and psychological condition. 
For about 22% of children, we were not able to establish 
the mother–baby linkage.
We developed history variables with up to 5 years of data 
(pharmacy, specialty, hospital admission and ER visit) for 
children in age strata 3–5 years old and 6–13 years old. 
Children who had conditions in any year from 2009 to 
2013 were flagged as having a utilisation history.
Modelling
Logistic regression was used to estimate predicted proba-
bilities for the occurrence of an inpatient hospital stay for 
the selected conditions, or death from any cause, for the 
individual patients. Since age and gender may be strongly 
correlated with children’s risk, we fit a total of six multi-
variable logistic regression models: female and male by 
age groups (1–2, 3–5 and 6–13 years old). All models were 
developed using SAS V.9.3 statistical software.
Model validation
The predicted accuracy of the modelling was evaluated using 
C-statistics (the area under the receiver operating charac-
teristics curve), comparing the results of the ‘predicted’ 
to the ‘observed’ outcomes in 2015. We stratified patients 
into risk strata based on the predicted risk of hospitalisa-
tion or death. ‘At higher risk’ was defined as children with 
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Table 1 Study population 2014
Total population
At higher risk Higher than average Lower than average
Risk >2.5% Risk >1.2%–2.5% Risk ≤1.2%
527 458 49 486 99 714 378 258
Number % Number % Number % Number %
Gender
  Female 255 875 48.5 20 315 41.1 43 030 43.2 192 530 50.9
  Male 271 583 51.5 29 171 58.9 56 684 56.8 185 728 49.1
Age group (years)
  1–2 78 051 14.8 18 112 36.6 44 084 44.2 15 855 4.2
  3–5 125 459 23.8 20 180 40.8 35 543 35.6 69 736 18.4
  6–13 323 948 61.4 11 194 22.6 20 087 20.1 292 667 77.4
Selected condition/body system
  Cancer 1138 0.2 477 1.0 252 0.3 409 0.1
  Cardiovascular 1624 0.3 653 1.3 211 0.2 760 0.2
  Dental conditions 442 0.1 138 0.3 109 0.1 195 0.1
  Endocrine 6458 1.2 1276 2.6 1074 1.1 4108 1.1
  Ear, nose, throat 31 919 6.1 21 664 43.8 7376 7.4 2879 0.8
  Eye 821 0.2 165 0.3 145 0.1 511 0.1
  Genetic conditions 274 0.1 188 0.4 29 0.0 57 0.0
  Gastrointestinal 7380 1.4 2724 5.5 1578 1.6 3078 0.8
  Genitourinary 3389 0.6 987 2.0 836 0.8 1566 0.4
  Obstetric and 
gynaecologic conditions 128 0.0 17 0.0 19 0.0 92 0.0
  Haematological 1114 0.2 596 1.2 247 0.2 271 0.1
  Hepatobiliary 245 0.0 82 0.2 39 0.0 124 0.0
  Immunological disease 199 0.0 80 0.2 45 0.0 74 0.0
  Infectious disease 869 0.2 596 1.2 160 0.2 113 0.0
  Male genital 1329 0.3 179 0.4 209 0.2 941 0.2
  Musculoskeletal 3817 0.7 664 1.3 453 0.5 2700 0.7
  Neurological diseases 3738 0.7 2123 4.3 912 0.9 703 0.2
  Nutrition 924 0.2 446 0.9 201 0.2 277 0.1
  Other conditions 1703 0.3 1150 2.3 247 0.2 306 0.1
  Neonatal conditions 186 0.0 111 0.2 50 0.1 25 0.0
  Psychological 854 0.2 388 0.8 141 0.1 325 0.1
  Respiratory 20 450 3.9 7285 14.7 5886 5.9 7279 1.9
  Skin 39 344 7.5 5809 11.7 7461 7.5 26 074 6.9
  Trauma 737 0.1 177 0.4 167 0.2 393 0.1
Emergency room visits based on severity level
  Critical 182 0.0 117 0.2 35 0.0 30 0.0
  Acute 15 029 2.8 5219 10.5 3915 3.9 5895 1.6
  Urgent but could be 
deferred 118 372 22.4 26 945 54.5 33 241 33.3 58 186 15.4
  Not urgent 45 336 8.6 11 216 22.7 13 080 13.1 21 040 5.6
Inappropriate medication 
prescriptions20 8077 1.5 2376 4.8 3090 3.1 2611 0.7
Antibiotic use
  1 114 421 21.7 8248 16.7 24 544 24.6 81 629 21.6
Continued
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a predicted risk greater than 2.5%. ‘Higher than average’ 
was defined as children with a predicted risk of hospitalisa-
tion or death between the mean rate and 2.5%. The rest of 
population was grouped into ‘Lower than average’. These 
risk strata were defined to yield a manageable number of 
patients to review for the typical paediatric panel of approx-
imately 800 patients. Calibration of the model across 
these risk groups was assessed by comparing observed to 
predicted rates among the risk groups. We also report the 
sensitivity, specificity and positive predictive value (PPV) for 
the defined risk group cut-offs.
results
Characterisation of risk groups
A total of 568 117 children ages 1–13 years resided in RER 
in 2014. We excluded from our analysis 40 659 children 
(7.2%) who did not reside in RER for the entire year, 
resulting in a population of 527 458 children. Of those, 6391 
children (1.21%) were hospitalised for selected conditions 
or died in 2015. Table 1 displays the distribution of gender, 
age category, presence of selected chronic conditions, ER 
visits, selected prescription drug usage, copay exemption 
for income or disability and specialty visits for the eligible 
RER residents as of 31 December 2014.
Table 1 also compares the characteristics of the total 
selected paediatric population to the subgroups of the 
population classified by risk categories based on the 
model results. Forty nine thousand four hundred and 
eighty-six children (9.4%) of the population were clas-
sified in the ‘At higher risk’ group using a threshold of 
predicted risk >2.5%. The children predicted to be 'At 
higher risk' were more likely to be male (58.9%) compared 
with 51.5% in the total population. The two youngest age 
strata (1–2 and 3–5 years) had much higher proportions 
of children identified in the 'At higher risk' group than 
the children aged 6–13 years. For example, 18 112 (23%) 
of the children age 1–2 years were identified in the 'At 
higher risk' group. This age category includes 36% of 
the 'At higher risk' children, although it represents 15% 
of the total paediatric population. Children in the ‘At 
higher risk’ category were more likely to have each of the 
selected conditions. When looking at the highest preva-
lence conditions, 43.8% of children in the ‘At higher risk’ 
category had an ear, nose or throat problem, compared 
with 6.1% in the overall population, 5.5% had a gastroin-
testinal problem compared with 1.4% in the overall popu-
lation, 4.3% had a neurological problem compared with 
0.7% in the overall population, 14.7% had a respiratory 
problem compared with 3.9% in the overall population 
and 11.7% had a skin problem compared with 7.5% in 
the overall population.
Children identified as being ‘At higher risk’ were much 
more likely to have a history of ER visits and were more 
likely to have a history of 2, 3 or more antibiotic prescrip-
tions. Overall, 14.6% of children had three or more anti-
biotic prescriptions, while in the ‘At higher risk’ category, 
51.7% had a history of 3 or more antibiotic prescriptions. 
Children with exemptions from copayments due to either 
family income or disability were more likely to be iden-
tified as being 'At Higher Risk' as were children with a 
history of medical or surgical specialty visits.
Table 2 displays information about the delivery (for 
the children age 1–5 years) and medical history of the 
mother for those children where we were able to match 
to their mother’s record. First children, children who 
were delivered by caesarean section and children where 
an abnormal birth weight or other problems were noted 
at birth were more likely to be classified in the ‘At higher 
risk’ category. If the mother was prescribed a potentially 
inappropriate drug or an antibiotic during pregnancy, 
the child was more likely to be classified in the ‘At higher 
risk’ category. When examining a 3-year medical history 
Total population
At higher risk Higher than average Lower than average
Risk >2.5% Risk >1.2%–2.5% Risk ≤1.2%
527 458 49 486 99 714 378 258
Number % Number % Number % Number %
  2 63 151 12.0 9359 18.9 19 035 19.1 34 757 9.2
  3+ 76 878 14.6 25 587 51.7 29 144 29.2 22 147 5.9
Non-Italian citizen 90 760 17.2 8975 18.1 18 390 18.4 63 395 16.8
Copay exempted based on 
family income/employment 
status 244 911 46.4 37 502 75.8 64 776 65.0 142 633 37.7
Copay exempted based on 
disabled status 6173 1.2 2029 4.1 1321 1.3 2823 0.7
Specialty visits in paediatrics
  Medical 12 642 2.4 3987 8.1 2735 2.7 5920 1.6
  Surgical 8982 1.7 2060 4.2 2294 2.3 4628 1.2
Table 1 Continued 
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of the mother, the mother’s asthma, cardiovascular 
disease, diabetes mellitus or mental health problems, 
or the record of a previous abortion, were all relatively 
frequent and more prevalent in the mothers of children 
predicted to be in the ‘At higher risk’ category.
Calibration
The population was divided into three risk groups based on 
predicted probability of hospitalisation as defined above. 
We observed good calibration; each stratum’s predicted 
risks were similar to observed prevalence of hospitalisations 
or deaths (figure 1). Individuals, who fell in the ‘At higher 
risk’ group, with predicted risk greater than 2.5%, had 
2683 predicted events based on the model results, and 2737 
observed events. While the overall rate of hospitalisation or 
death for children ages 1–13 years was 1.21%, the predicted 
and observed risk of the ‘At higher risk’ group was over 5%.
Model performance among risk groups
We observed a C-statistic of 0.78 indicating good model 
performance (table 3). The sensitivity (proportion 
Table 2 Birthing and medical history of mother*
Total population
At higher risk Higher than average Lower than average
Risk >2.5% Risk >1.2%–2.5% Risk ≤1.2%
203 510 38 292 79 627 85 591
Number % Number % Number % Number %
Birthing
  Age at delivery (years)†
   24 and less 12 728 6.3 3275 8.6 5651 7.1 3802 4.4
   25–34 88 370 43.4 18 227 47.6 35 681 44.8 34 462 40.3
   35–39 45 575 22.4 8170 21.3 17 679 22.2 19 726 23.0
   40 and over 12 529 6.2 2344 6.1 4528 5.7 5657 6.6
  First delivery 99 190 48.7 23 336 60.9 42 662 53.6 33 192 38.8
  C-section 48 282 23.7 11 370 29.7 19 480 24.5 17 432 20.4
  Baby’s birth condition
   Normal newborns 172 497 84.8 30 214 78.9 67 522 84.8 74 761 87.3
   Abnormal birth weight 20 128 9.9 4757 12.4 7756 9.7 7615 8.9
   Other abnormal birth 
condition 10 885 5.3 3321 8.7 4349 5.5 3215 3.8
Medical history
  Number of ordinary hospitalisation 1 year before delivery
    1 16 145 7.9 4578 12.0 6856 8.6 4711 5.5
   2+ 3920 1.9 1670 4.4 1500 1.9 750 0.9
  Inappropriate prescription during pregnancy
   Class D 10 594 5.2 2970 7.8 3886 4.9 3738 4.4
   Class X 4874 2.4 1086 2.8 1811 2.3 1977 2.3
  Antibiotic use during 
pregnancy 60 679 29.8 14 422 37.7 25 757 32.3 20 500 24.0
  3-year history before delivery
   Abortion 19 919 9.8 4970 13.0 8165 10.3 6784 7.9
   Asthma 35 590 17.5 9026 23.6 14 894 18.7 11 670 13.6
   Bacterial pneumonia 188 0.1 36 0.1 14 0.0 138 0.2
   Cardiovascular disease 18 756 9.2 5068 13.2 7742 9.7 5946 6.9
   Diabetes 2602 1.3 1003 2.6 1106 1.4 493 0.6
   Hypertension 140 0.1 51 0.1 39 0.0 50 0.1
   Infection 935 0.5 283 0.7 325 0.4 327 0.4
   Psychological 
condition 9215 4.5 2701 7.1 3709 4.7 2805 3.3
*Information about the delivery was considered only for children 1–5 years old.
†For 22% of children, we were not able to establish the mother–baby linkage.
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predicted to be at higher risk of those who had an event 
in 2015) was 0.43 and 0.70 for predicted risk categories 
of ‘At higher risk’ and ‘Higher than average’, respec-
tively (table 4). In other words, among those whom were 
hospitalised or deceased in 2015, 43% were predicted to 
have risk greater than 2.5% of hospitalisation or death 
and 70% have risk higher than average. The specificity 
(proportion predicted to be at a ‘lower’ risk of those who 
did not have an event) was 0.91 and 0.72 for the predicted 
‘At higher’ and ‘Higher than average’ risk categories, 
respectively; among those who were not hospitalised and 
did not die in 2015, 91% were not predicted to be ‘At 
higher risk’. The PPV (proportion with an event of those 
who were predicted to be at an elevated risk) was 0.06 
and 0.03 for the ‘At higher’ and ‘Higher than average’ 
predicted risk categories, respectively. In other words, of 
those individuals who were estimated to have a >2.5% risk 
of hospitalisation or death approximately 6% had an 
event in 2015. (Regression coefficients and significance 
levels of independent variables for multivariable logistic 
regression models for each the six age and gender strata 
are included in online supplementary appendix 3).
DIsCussIOn
We have developed a population-based model that identi-
fies risk of hospitalisation for potentially preventable prob-
lems in a paediatric population including all children under 
the age of 14 years living in the RER of Italy. The C-statistic 
of 0.78 indicates that the model performs well. By compar-
ison, in a study predicting high-cost paediatric patients, 
Leininger et al reported a C-statistic of 0.73.9 In their work in 
predictive risk modelling in the UK, Billings et al reported 
a C-statistics of 0.68523 and C-statistics ranging from 0.731 
to 0.780.24 However, neither of these papers focused on a 
paediatric population. In a project also conducted in the 
Emilia-Romagna region of Italy but focused on the adult 
population, Louis et al11 reported a C-statistic of 0.856. Given 
the similar organisation of the healthcare system and the 
similar database used for the adult and paediatric analyses, 
Figure 1 Model calibration: predicted and observed prevalence of hospitalisation or death in 2015 by risk category.
Table 3 Observed and predicted events by risk group
Risk groups
(predicted risk range) N
Average
predicted risk, %
Observed 
prevalence, %
Expected frequency 
based on predicted risk
Number of 
observed events
Lower than average (≤1.2%) 378 258 0.5 0.5 2018 1896
Higher than average 
(>1.2%–2.5%)
99 714 1.7 1.8 1690 1758
At higher risk (>2.5%) 49 486 5.4 5.5 2683 2737
Total 527 458 1.2 6391 6391
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we believe that the somewhat lower C-statistic in the paedi-
atric study results form the fact that hospitalisation is less 
frequent in children.
We believe that the definition of the dependent vari-
able used in our models increases the likelihood that 
they are identifying patients whose risk may be reduced 
through proactive care. We have updated previously 
published criteria to include hospitalisations that may 
have been prevented by currently available vaccines, and 
we have used the logic of disease staging to include rele-
vant hospitalisations that would have been missed using 
solely primary ICD-9-CM codes. Specifics of the selection 
criteria are available in the supplemental material.
The richness of the administrative data available in the 
RER allowed for a robust definition of the predictive vari-
ables. The RER data allow for the linkage of patients’ use 
of diverse inpatient and outpatient healthcare services 
over multiple years. In addition, the ability to link child 
and mother’s information allows the models to consider 
some of the mother’s medical history such as the pres-
ence of chronic disease and use of prescription drugs in 
the years prior to birth as well as complications that may 
have arisen at birth.
There are limitations to our models. The models were 
developed with administrative data that lack some of the 
clinical specificity that would be useful in assessing patient 
risk. Children who have not had the types of encounters 
included in the RER database would have potentially 
missing information. The RER database does not have 
encounter level diagnostic data available documenting 
visits with the primary care paediatrician. The administra-
tive data have very limited information available about the 
patient and family socioeconomic status. Our models use 
prior utilisation among the predictor variables. With the 
administrative date, we cannot distinguish appropriate 
from inappropriate prior utilisation, which may bias our 
results. Despite their limitations, administrative data have 
many advantages for a project such as ours. They are rela-
tively inexpensive to analyse and, in the case of the RER, 
include a large population over multiple years.
While the evidence was mixed, a systematic review 
suggests that hospitalisations can be prevented in children 
with medical complexity.1 The Local Health Authority of 
Parma has begun working with the primary care paedia-
tricians caring for the patients identified by the models 
to develop individual ‘profiles’ of children identified 
as being at higher risk. Data in the profiles, along with 
the more detailed information available in the medical 
record, can be used by the paediatricians to assess what 
additional intervention, if any, may help to manage the 
child’s risk. For example, review of the profiles of higher 
risk children can help identify children whose parents 
might be contacted for a visit if they have not been seen 
recently. Summaries of prescriptions that have been 
filled from the profiles can be reviewed for potential over 
use, under use or inappropriate use of mediation. High-
risk children with chronic illness might be referred to a 
specialist or home healthcare provided.
The RER healthcare system offers several advantages 
in the goal of reducing potentially preventable hospi-
talisation. Every child is enrolled with a primary care 
paediatrician. The population is quite stable allowing for 
continuity of care. Through the Italian NHS, every child 
is entitled to healthcare with little or no cost at the point 
of service. While the primary care paediatricians are paid 
on a per-capita basis, the RER can negotiate incentive 
payments and monitor improvements in care that may 
help to reduce avoidable hospitalisations. If successful, 
the results of the models can be applied by other Local 
Health Authorities in the RER, other Italian regions and 
other countries with similar data availability.
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